News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Colin Hayward, FFPM

Advertisement

Articles by Colin Hayward, FFPM

Small Biotechs Gain As the Span of Clinical Trial Outsourcing Grows

ByColin Hayward, FFPM
September 18th 2018

Pharmaceutical Executive

Small biotech companies benefit more from partnering with CROs rather than hiring a chief medical officer.

Advertisement

Latest Updated Articles

  • Small Biotechs Gain As the Span of Clinical Trial Outsourcing Grows
    Small Biotechs Gain As the Span of Clinical Trial Outsourcing Grows

    September 18th 2018



Advertisement
Advertisement

Trending on PharmExec

1

Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer

2

New Study Reveals Genetic Predictors for GLP-1 Weight Loss and Side Effects

3

Aradhana Sarin: The CFO as a Catalyst

4

Amgen’s Tarlatamab Approved in China

5

The Complex Usage and Impact of GLP-1 Usage: Q&A with Mark Bagnall

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us